Norwalk, CT - November 8, 2024 – LifeSpan Vision Ventures today announced a follow-on investment in EpiBone. EpiBone is a regenerative medicine company that is developing technology to create living bone and cartilage grafts from mesenchymal stem cells in vitro for use in skeletal repair. The Company hopes to launch a Phase 3 clinical trial of its bone graft product with its first therapeutic application, for craniomaxillofacial repair. Alongside this, EpiBone expects to launch two Phase 1/2a clinical trials for its cartilage products for use in joints like the knee.
Andrew Worden, Founding Partner of LifeSpan Vision Ventures, stated, “Our follow-on investment in EpiBone emphasizes our confidence in the company’s management team to deliver solutions that transform skeletal repair. EpiBone’s current focus is on bone and cartilage indications, but their platform technology has great promise for repair throughout the body, offering great potential for the treatment of age-related diseases. We are excited to support such a talented team of pioneers in and look forward to seeing how they translate their promising research into therapies for orthopaedic repair.”
Nina Tandon, CEO and Co-Founder of Epibone, stated, “At EpiBone, we believe our technology can play a pivotal role in addressing the longevity challenges of our time. Skeletal health is human health - by creating living bone and cartilage from living cells, we’re not only improving quality of life for people suffering from skeletal conditions but also contributing to a broader vision of extending healthy human lifespan. This is truly a longevity technology, and we are excited about its potential to impact human health on a global scale.”
About EpiBone
EpiBone, Inc. is privately held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.
For more information, please visit: https://www.epibone.com/
Contact: Contact: Carla Nassy, Director of Administration - carla@epibone.com
About LifeSpan Vision Ventures
LifeSpan Vision Ventures LLC is a forward-thinking investment firm specializing in investments within the aging and longevity space. Our mission is to support and accelerate the development of innovative therapies that extend healthspan, improve the quality of life for individuals as they age, and address age-related challenges. Through strategic partnerships and investments, we aim to shape a future where aging is met with vitality, resilience, and endless possibilities.
Contact: Harry Robb, Analyst - harry.robb@lifespanvision.com
Comments